-
2018 PM Society Digital Awards winners announced
pharmatimes
September 27, 2018
Last night saw the ninth PM Society Digital Awards take place at The Brewery in London. 450 guests sat down to dinner before the winners...
-
Teva attracts attention from pharma, private equity for $500M sale of Medis
fiercepharma
September 14, 2018
Teva has been working to pay down tens of billions of dollars of debt since it purchased Allergan’s generics suite for more than $40 billion. Now, the company's Medis unit has attracted attention from industry players and private equity firms, according t
-
Strides Pharma’s promoter sells stake worth ₹20 cr
financialexpress
September 10, 2018
According to the block deal data available with the NSE, Abusha offloaded 4 lakh shares, amounting to 0.45 per cent stake in the firm
-
Pharma reps get more respect from doctors in Japan. What's the takeaway for U.S. reps?
fiercepharma
August 07, 2018
Looking for a place where pharma sales reps are respected and influential? Try Japan.
-
EUSA Pharma’s tivozanib drug approved for kidney cancer in Scotland
pharmaceutical-technology
July 12, 2018
Scotland’s pharmaceutical regulatory authority the Scottish Medicines Consortium (SMC) has recommended Jazz Pharmaceutical spin-off EUSA Pharma’s fotivda (tivozanib) for the first line treatment of adults with advanced renal cell carcinoma (RCC).
-
Forendo Pharma Initiates Endometriosis Study
americanpharmaceuticalreview
July 11, 2018
Forendo Pharma has received clinical trial authorization (CTA) from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to commence a study for its lead program FOR-6219.
-
Huddersfield Uni launches pharma policy and practice research centre
pharmatimes
July 10, 2018
The University of Huddersfield has launched the Centre for Pharmaceutical Policy and Practice Research, tasked with keeping the industry “armed with the latest research methods and advice”.
-
Pharma shells out $100B on M&A in 2018 so far, with more to come
fiercepharma
July 09, 2018
After an unusually slow 2017, deal-making in Big Pharma roared back to life in the first half of this year, with $100 billion spent on mergers and acquisitions so far.
-
Sebi to act against pharma cos in case of non-disclosure of material information
financialexpress
June 29, 2018
Markets regulator Sebi said it would take action against pharma companies if they are found not sharing information on material events like inspections and reports by the US FDA.
-
Can Cannes push the pharma ad envelope? Record number of Lions wins hint at yes
fiercepharma
June 26, 2018
If the first few years of the Cannes Lions Health served to inspire pharma advertising creativity, this year was the payoff.